November 28, 2017 / 1:38 PM / 18 days ago

BRIEF-PhaseRx Receives Positive Opinion for Orphan Drug Designation for PRX-ASL from EMA

Nov 28 (Reuters) - PhaseRx Inc:

* PHASERX RECEIVES POSITIVE OPINION FOR ORPHAN DRUG DESIGNATION FOR PRX-ASL FROM EUROPEAN MEDICINES AGENCY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below